Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis.

Ann Rheum Dis · 2024 · PMC11103324 · PMID 38503473

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Outcomes assessing other domains besides dactylitis (enthesitis, tender joints, swollen joints, skin, physical function) showed a trend towards better efficacy for the combination therapy arm, without significant differences between the arms. 15 Four trials (two with low RoB, two with unclear RoB) investigated SEC (anti-IL-17A) treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.